Editors:
- Thoroughly updated edition focusing on new and recent developments in renal cell carcinoma
- Provides updated information on the rapidly evolving field of renal cell carcinoma personalized medicine, with an emphasis on novel targets and therapy
- Discusses the significant amount of new biologic and clinical information such as refinement of the RCC systemic treatment paradigm, immunoregulatory abnormalities in RCC, and adjuvant and neoadjuvant therapy?
- Includes supplementary material: sn.pub/extras
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (26 chapters)
-
Front Matter
About this book
The third edition of this critically acclaimed book has updated and expanded the survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. Internationally renowned editors and contributors explore the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors.
Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Third Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by leaders of the field.
Reviews
From the book reviews:
“This is an important reference for practicing medical oncologists, urologists, and researchers interested in the biology and therapy of this disease. … This book details the most recent research into the molecular targets of RCC and applications for clinical drug development. … It should be part of libraries for clinicians or basic scientists dealing with RCC. It certainly is an excellent reference for basic and translational scientists and clinicians in this field.” (Jianqing Lin, Doody’s Book Reviews, February, 2015)
Editors and Affiliations
-
Taussig Cancer Center, Cleveland Clinic, Pepper Pike, USA
Ronald M. Bukowski
-
Division of Hematology Oncology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, USA
Robert A. Figlin
-
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA
Robert J. Motzer
About the editors
Ronald M Bukowski MD
Emeritus Staff Physician
Cleveland Clinic Taussig Cancer Center
Professor Emeritus of Medicine
CCF Lerner College of Medicine of CWRU
Robert Figlin MD
Professor of Medicine and Biomedical Sciences
Director, Division of Hematology Oncology
Department of Medicine, Cedars-Sinai Medical Center
Associate Director for Academic Programs
Samuel Oschin Comprehensive Cancer Institute
Professor Emeritus of Medicine and Urology
David Geffen School of Medicine at UCLA
Robert Motzer MD
Attending Physician
Department of Medicine
Memorial Sloan-Kettering Cancer Center
Professor of Medicine
Weil Medical College of Cornell University
Bibliographic Information
Book Title: Renal Cell Carcinoma
Book Subtitle: Molecular Targets and Clinical Applications
Editors: Ronald M. Bukowski, Robert A. Figlin, Robert J. Motzer
DOI: https://doi.org/10.1007/978-1-4939-1622-1
Publisher: Springer New York, NY
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Science+Business Media New York 2015
Hardcover ISBN: 978-1-4939-1621-4Published: 27 November 2014
Softcover ISBN: 978-1-4939-5063-8Published: 23 August 2016
eBook ISBN: 978-1-4939-1622-1Published: 27 November 2014
Edition Number: 3
Number of Pages: XVIII, 613
Number of Illustrations: 9 b/w illustrations, 41 illustrations in colour
Topics: Oncology, Nuclear Medicine